Los altavoces inteligentes se han convertido rápidamente en una parte integral de nuestros hogares. Estos dispositivos combinan la comodidad de la tecnología moderna con la versatilidad de la inteligencia artificial para brindarnos una experiencia auditiva inigualable. En este art&iacu …
Los altavoces inteligentes: la revolución de la tecnología en tu hogar Read More »
Curasight A/S is pleased to announce preclinical data demonstrating the effectiveness of uTREAT® in treating aggressive brain cancer.
While several effective treatments are currently available for the treatment of alcohol withdrawal syndrome, there is an unmet medical need in the abstinence maintenance phase.
Axol Bioscience Ltd., a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease patient samples.
XNK Therapeutics announced the appointment of Hugo Petit as Chief Financial Officer and member of the company’s leadership team.
XNK Therapeutics appoints Hugo Petit as Chief Financial Officer Read More »
ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT and MVR-T3011 IV in both U.S. and China with all selected to be published at the 2023 American Society for Clinical Oncology Annual Meeting taking place from June 2nd to 6th, 2023 in Chicago, IL.
IRay Technology Co., Ltd., a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.
Cellusion Inc. announced that it has raised 2.83 billion yen in Series C Round financing.
Cellusion raises 2.83 Billion Yen (21 Million USD) in Series C Round Read More »
CymaBay Therapeutics, Inc. announced it will make three presentations at the European Association for the Study of the Liver ‘s The International Liver Congress™ 2023.
Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock, offered at a public offering price of $12.00 per share.
